DUBLIN, July 10, 2018 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global pharmaceutical company, today announced the launch of a new over-the-counter (OTC) artificial tear formulation, REFRESH ...
In a Clinical Study, Patients Report Significant Reduction in Dry Eye Symptoms in Just 30 Days of Usage DUBLIN, Oct. 21, 2015 /PRNewswire/ -- Allergan plc, (NYSE: AGN), a leading global pharmaceutical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results